Ingevity SVP granted 1,262 restricted stock units

PLATT PHILLIP JOHN reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

PLATT PHILLIP JOHN reported acquisition or exercise transactions in this Form 4 filing.

Ingevity Corp senior vice president of finance and chief accounting officer Phillip John Platt received a grant of 1,262 restricted stock units (RSUs) of common stock on May 1, 2026. This was awarded under the Ingevity Corporation 2025 Omnibus Incentive Plan and is compensation rather than a market purchase.

The RSUs will vest in three equal installments on May 1, 2027, 2028, and 2029, meaning the shares are earned over time if service conditions are met. After this award, Platt directly holds 31,633 shares of Ingevity common stock, which includes 422 shares purchased through the company’s Employee Stock Purchase Plan for the period from January 1, 2026 to March 31, 2026 at a price equal to 85% of the December 31, 2025 closing price.

Insider Trade Summary

Grant/Award: 1,262 shares

Grant/Award 1 txn

Insider PLATT PHILLIP JOHN

Role SVP, Finance & CAO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,262	$0.00	$0.00

Holdings After Transaction: Common Stock — 31,633 shares (Direct)

Footnotes (2)

1. F1. Grant of restricted stock units ("RSUs") pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, which will vest in three equal installments on May 1, 2027, 2028, and 2029.
2. F2. Includes 422 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP"), for the purchase period of January 1, 2026 to March 31, 2026. In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2025.

Key Figures

RSU grant size: 1,262 units Shares held after grant: 31,633 shares ESPP shares included: 422 shares +1 more

4 metrics

RSU grant size 1,262 units Restricted stock units granted May 1, 2026

Shares held after grant 31,633 shares Total direct common stock holdings following transaction

ESPP shares included 422 shares Purchased under ESPP for Jan 1–Mar 31, 2026 period

ESPP purchase discount 85% of closing price Based on December 31, 2025 closing stock price

Key Terms

restricted stock units ("RSUs"), Omnibus Incentive Plan, Employee Stock Purchase Plan, vesting

4 terms

restricted stock units ("RSUs") financial

"Grant of restricted stock units ("RSUs") pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Omnibus Incentive Plan financial

"pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, which will vest in three equal installments"

An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.

Employee Stock Purchase Plan financial

"purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP")"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

vesting financial

"which will vest in three equal installments on May 1, 2027, 2028, and 2029"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ingevity (NGVT) executive Phillip John Platt report in this Form 4?

Phillip John Platt reported receiving 1,262 restricted stock units (RSUs) of Ingevity common stock as a compensation grant. The award was made on May 1, 2026 and did not involve any open-market stock purchase or sale.

How and when will Phillip John Platt’s new Ingevity (NGVT) RSUs vest?

The 1,262 RSUs granted to Phillip John Platt will vest in three equal installments on May 1, 2027, May 1, 2028, and May 1, 2029. Vesting means the units convert into shares over time if conditions are satisfied.

How many Ingevity (NGVT) shares does Phillip John Platt hold after this transaction?

After the RSU grant, Phillip John Platt directly holds 31,633 shares of Ingevity common stock. This figure includes 422 shares acquired through the company’s Employee Stock Purchase Plan during the January 1 to March 31, 2026 purchase period.

What is the role of Ingevity’s 2025 Omnibus Incentive Plan in this Form 4?

The 2025 Omnibus Incentive Plan is the compensation program under which the 1,262 RSUs were granted. Such plans provide equity-based awards to executives, linking a portion of compensation to company stock performance and long-term service.

How were the ESPP shares mentioned in the Ingevity (NGVT) Form 4 priced?

The 422 ESPP shares noted in the filing were purchased at 85% of the closing price of Ingevity’s common stock on December 31, 2025. This discount reflects standard Employee Stock Purchase Plan terms for the January 1 to March 31, 2026 period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 05:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PLATT PHILLIP JOHN

(Last) (First) (Middle)

4920 O'HEAR AVE

SUITE 400

(Street)

NORTH CHARLESTON SOUTH CAROLINA 29405

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Finance & CAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/01/2026		A		1,262(1)	A	$0	31,633(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units ("RSUs") pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, which will vest in three equal installments on May 1, 2027, 2028, and 2029.

2. Includes 422 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP"), for the purchase period of January 1, 2026 to March 31, 2026. In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2025.

Remarks:

	Phillip J. Platt By: Mavis Huger as Attorney-in-Fact	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)